Sarcoma (soft tissue tumor) is a very rare type of cancer with many subgroups. Therefore, pathologic evaluation alone is insufficient to identify subgroups. For this reason, it is recommended that comprehensive genetic tests, including DNA and fusion RNA tests, should be performed to determine the type of cancer in line with the recommendations of international guidelines.